YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer

Phase 1

Recruiting

Conditions: Non-small Cell Lung Cancer

Interventions: Radiation: 45 Gray (Gy) regimen

First Posted Date: 2019-12-24

Last Posted Date: 2024-06-27

Lead Sponsor: Yale University

Target Recruit Count: 36

Registration Number: NCT04210492

Locations: 🇺🇸
Smilow Cancer Hospital, New Haven, Connecticut, United States

Mobile Physical Activity for Type 1 Diabetes

Not Applicable

Completed

Conditions: Type1diabetes

First Posted Date: 2019-12-19

Last Posted Date: 2021-05-06

Lead Sponsor: Yale University

Target Recruit Count: 20

Registration Number: NCT04204733

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Cannabis Use and Relapse After One Week of Contingency Management Therapy

Not Applicable

Completed

Conditions: Cannabis Dependence

Interventions: Behavioral: Contingency Management + Motivational Interviewing

First Posted Date: 2019-12-17

Last Posted Date: 2021-11-11

Lead Sponsor: Yale University

Target Recruit Count: 49

Registration Number: NCT04202146

Locations: 🇺🇸
The Yale Stress Center: Yale University, New Haven, Connecticut, United States

THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis

Phase 1

Completed

Conditions: Cannabis
Ketamine

Interventions: Drug: Active Delta-9-THC
Drug: Placebo Delta-9-THC
Drug: Active Ketamine
Drug: Placebo Ketamine

First Posted Date: 2019-12-16

Last Posted Date: 2024-03-25

Lead Sponsor: Yale University

Target Recruit Count: 22

Registration Number: NCT04199468

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Combining Varenicline and Guanfacine for Smoking Cessation

Phase 2

Recruiting

Conditions: Smoking Cessation

Interventions: Drug: Varenicline
Drug: Guanfacine ER

First Posted Date: 2019-12-13

Last Posted Date: 2024-08-12

Lead Sponsor: Yale University

Target Recruit Count: 140

Registration Number: NCT04198116

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

vDPP Facilitated With Community Care Coordination

Not Applicable

Completed

Conditions: Diabetes Prevention

Interventions: Behavioral: vDPP

First Posted Date: 2019-12-12

Last Posted Date: 2024-11-18

Lead Sponsor: Yale University

Target Recruit Count: 96

Registration Number: NCT04195477

Locations: 🇺🇸
Griffin Hospital, Derby, Connecticut, United States
🇺🇸
Yale University, New Haven, Connecticut, United States

Effect of Physician Race and Gender on Simulated Patients' Ratings

Not Applicable

Completed

Conditions: Physician-Patient Relations
Bias, Sex
Patient Satisfaction
Bias, Racial

Interventions: Behavioral: Simulated White Male Physician
Behavioral: Simulated White Female Physician
Behavioral: Simulated Black Male Physician
Behavioral: Simulated Black Female Physician

First Posted Date: 2019-12-09

Last Posted Date: 2020-07-21

Lead Sponsor: Yale University

Target Recruit Count: 3592

Registration Number: NCT04190901

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Neurofeedback in Individuals With Substance Use Disorders

Not Applicable

Terminated

Conditions: Opioid-Related Disorders

Interventions: Device: Experimental feedback
Device: Control feedback
Device: fMRI

First Posted Date: 2019-12-05

Last Posted Date: 2024-03-26

Lead Sponsor: Yale University

Target Recruit Count: 12

Registration Number: NCT04188288

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Study of Pembrolizumab and Ramucirumab in Pts With Progressive TCC After Treatment With an Immune Checkpoint Inhibitor

Phase 2

Withdrawn

Conditions: Transitional Cell Carcinoma

Interventions: Drug: Pembrolizumab and Ramucirumab

First Posted Date: 2019-11-27

Last Posted Date: 2022-02-22

Lead Sponsor: Yale University

Registration Number: NCT04179110

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Coordinating Opioid Use Treatment Through Medical Management With Infection Treatment (Project COMMIT)

Not Applicable

Completed

Conditions: Opioid-use Disorder

Interventions: Other: ID/LAB
Other: TAU

First Posted Date: 2019-11-27

Last Posted Date: 2024-07-31

Lead Sponsor: Yale University

Target Recruit Count: 171

Registration Number: NCT04180020

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States
🇺🇸
Prisma Health, Greenville, South Carolina, United States
🇺🇸
Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy